FrancophonIA/ELRC3.0 huggingface dataset:
English: ¾ The lack of experience in patients with HIV infection or active hepatitis, with severe immunological diseases (e.g. multiple sclerosis, lupus erythematous, multifocal leukoencephalopathy) or treated with immunosuppressive therapy (other than short-term systemic corticosteroids) and that Libertek should not be initiated or should be stopped in these patients.
Slovenian: ¾ Pomanjkanje izkušenj pri bolnikih z okužbo HIV ali aktivnim hepatitisom, z resnimi imunološkimi boleznimi (npr. multiplo sklerozo, eritematoznim lupusom, multifokalno leukoencefalopatijo) ali na zdravljenju z imunosupresivnimi zdravili (razen kratkotrajnega zdravljenja s sistemskimi kortikosteroidi) in zdravila Libertek se pri teh bolnikih ne sme uvajati oz. ga je treba ukiniti.
English: The fact that Libertek is not indicated for the treatment of COPD patients other than those covered by the approved indication, nor for use in patients with asthma or alpha 1 anti trypsine deficiency.
Slovenian: Dejstvo, da zdravilo Libertek ni indicirano za zdravljenje bolnikov s KOPB, razen tistih, ki ustrezajo odobreni indikaciji, ni primeren za uporabo pri bolnikih z astmo ali pomanjkanjem alfa-1-antitripsina.
English: Libertek should not be initiated or should be stopped in patients with cancers (except basal cell carcinoma).
Slovenian: Zdravila Libertek se ne sme uvajati oz. ga je treba ukiniti pri bolnikih z rakom (z izjemo bazalnoceličnega karcinoma).
English: • The Marketing Authorisation Holder (MAH) should ensure that, at launch, all Healthcare Professionals who are expected to prescribe Libertek are provided with an Educational pack.
Slovenian: • Imetnik dovoljenja za promet z zdravilom mora zagotoviti, da bodo imeli ob uvajanju vsi zdravniki, ki bodo predpisovali zdravilo Libertek, na razpolago izobraževalno gradivo.
English: ¾ The potential risk of infections: Libertek should not be initiated, or treatment should be stopped, in patients with severe acute infectious diseases.
Slovenian: ¾ Potencialno tveganje za okužbe: zdravila Libertek se ne sme uvajati oz. zdravljenje je treba prekiniti pri bolnikih z resnimi oblikami akutnih infekcijskih bolezni.
English: ¾ The risk of psychiatric disorders such as insomnia, anxiety, depression in patients receiving Libertek and the potential risk of suicide.
Slovenian: ¾ Tveganje za psihiatrične motnje, npr. nespečnost, tesnobo, depresijo, pri bolnikih, ki jemljejo zdravilo Libertek in potencialno tveganje za samomor.
English: • Summary of Product Characteristics and Patient Information Leaflet for Libertek
Slovenian: • Povzetek glavnih značilnosti zdravila in Navodilo za uporabo zdravila Libertek
English: That Libertek may cause weight loss and patients should weigh themselves regularly and record their weight on the patient card.
Slovenian: Da zdravilo Libertek lahko povzroči izgubo telesne mase in, da se morajo redno tehtati ter beležiti svojo telesno maso na kartico za bolnike.
English: 14 January 2016 EMA/168579/2015
Slovenian: 14. januar 2016 EMA/168579/2015
English: Ambroxol and bromhexine medicines have been authorised in: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain and Sweden.
Slovenian: Zdravila z ambroksolom in bromheksinom so bila odobrena: v Avstriji, Belgiji, Bolgariji, na Hrvaškem, Cipru, v Češki republiki, na Danskem, v Estoniji, na Finskem, v Franciji, Nemčiji, Grčiji, na Madžarskem, v Islandiji, na Irskem, v Italiji, Latviji, Litvi, Luksemburgu, na Malti, Nizozemskem, Norveškem, Poljskem, Portugalskem, v Romuniji, na Slovaškem, v Sloveniji, Španiji in na Švedskem.
English: As these medicines have been authorised via national procedures, approved uses are not the same in all EU countries.
Slovenian: Ker so bila ta zdravila odobrena po nacionalnih postopkih, odobrena uporaba ni enaka v vseh državah EU.
English: The review of ambroxol and bromhexine was initiated on 4 April 2014 at the request of Belgium, under Article 31 of Directive 2001/83/EC.
Slovenian: Pregled ambroksola in bromheksina se je začel 4. aprila 2014 na zahtevo Belgije v skladu s členom 31 Direktive 2001/83/ES.
English: Frequencies of these side effects are unknown.
Slovenian: Pogostnost teh neželenih učinkov ni znana.
English: 1 The CMDh is a medicines regulatory body representing the European Union (EU) Member States.
Slovenian: 1 Skupina CMDh je regulativni organ za zdravila, ki zastopa države članice Evropske unije (EU).
English: The majority of these medicines are available over the counter, whereas some are prescription-only medicines, depending on the condition to be treated and how the treatment is given.
Slovenian: Večina teh zdravil je na voljo brez recepta, nekatera pa so samo na recept, odvisno od zdravljenega stanja in načina dajanja.
English: This position was then sent to the European Commission which issued an EU-wide legally binding decision on 14/01/2016.
Slovenian: Stališče so nato posredovali Evropski komisiji, ki je 14. 1. 2016 izdala končno pravno zavezujočo odločbo za vso EU.
English: Risk of allergy and skin reactions included in the product information
Slovenian: Tveganje za alergijo in reakcije na koži vključeno v informacije o zdravilu
English: As the CMDh position was adopted by majority vote, it was sent to the European Commission, which endorsed it and issued an EU-wide legally binding decision.
Slovenian: Ker je skupina CMDh svoje stališče sprejela z večino glasov, so ga poslali Evropski komisiji, ki ga je podprla in izdala končno pravno zavezujočo odločbo za vso EU.
English: Reports of severe allergic reactions and SCARs in patients taking the medicines are rare, and the frequencies of these side effects are unknown.
Slovenian: Poročila o resnih alergijskih reakcijah in SCAR pri bolnikih, ki jemljejo ta zdravila, so redka, pogostnosti teh neželenih učinkov pa so neznane.
English: The CMDh first adopted a position by majority vote in February 2015, following which the European Commission requested clarifications on the PRAC recommendation and CMDh position.
Slovenian: Skupina CMDh je najprej februarja 2015 sprejela stališče z večino glasov, nato pa je Evropska komisija zahtevala pojasnila o priporočilu odbora PRAC in stališču CMDh.
English: Ambroxol and bromhexine expectorants: safety information updated
Slovenian: Ekspektoransi z ambroksolom in bromheksidinom: posodobljene informacije o varnosti
English: A revised CMDh position was subsequently adopted, by majority vote in November 2015.
Slovenian: Novembra 2015 je bilo z večino glasov sprejeto revidirano stališče skupine CMDh.
English: Some of these injectable formulations are also used to increase lung development before birth.
Slovenian: Nekateri izmed teh pripravkov za injiciranje se uporabljajo tudi za pospešitev razvoja pljuč pred rojstvom.
English: As ambroxol- and bromhexine-containing medicines are all authorised nationally, the PRAC recommendation was forwarded to the Co-ordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh), for a position.
Slovenian: Ker so vsa zdravila, ki vsebujejo ambroksol in bromheksin, odobrena na nacionalni ravni, so bila priporočila odbora PRAC posredovana Usklajevalni skupini za postopek z medsebojnim priznavanjem in decentralizirani postopek - zdravila za uporabo v humani medicini (CMDh), ki je morala sprejeti stališče.
English: • If you are taking ambroxol or bromhexine and have any questions or concerns speak to your doctor of pharmacist.
Slovenian: • Če jemljete ambroksol ali bromheksin in imate vprašanja ali vas kaj skrbi, se pogovorite z zdravnikom ali farmacevtom.
English: • If you experience skin reactions such as skin swellings or rash, stop treatment immediately and contact your doctor.
Slovenian: • Če se pri vas pojavijo kožne reakcije, kot je otekanje kože ali izpuščaj, nemudoma prekinite zdravljenje in se obrnite na svojega zdravnika.
English: The recommendations were originally made by EMA's Pharmacovigilance Risk Assessment Committee (PRAC), which confirmed the previously known risk of allergic reactions and also identified a small risk of SCARs, a group of skin conditions which include erythema multiforme and Stevens-Johnson syndrome.
Slovenian: Priporočila je prvotno pripravil Odbor za oceno tveganja na področju farmakovigilance (PRAC) agencije EMA, ki je potrdil predhodno znano tveganje za alergijske reakcije in ugotovil manjše tveganje za SCAR, skupino kožnih stanj, ki vključujejo multiformni eritem in Stevens-Johnsonov sindrom.
English: The medicines are widely available in the EU for use as expectorants (to help clear mucus from the airways).
Slovenian: Ta zdravila so v EU široko dostopna in se uporabljajo kot ekspektoransi (za pomoč pri čiščenju sluzi iz dihal).
English: As a result, SCARs are now listed as side effects in the product information for these medicines, and patients are to stop treatment immediately if symptoms of SCARs occur.
Slovenian: Zato so SCAR zdaj navedeni kot neželeni učinki v informacijah o zdravilu za ta zdravila, bolniki pa morajo v primeru pojava simptomov SCAR zdravljenje nemudoma prekiniti.
English: Injectable formulations are also used to prevent and treat lung complications following surgery.
Slovenian: Pripravki za injiciranje se uporabljajo tudi za preprečevanje in zdravljenje zapletov s pljuči po kirurškem posegu.
English: • Advise your patients that they should stop treatment immediately if symptoms of progressive skin rash occur.
Slovenian: • Bolnikom svetujte, naj v primeru pojava simptomov napredujočega izpuščaja na koži nemudoma prekinejo zdravljenje.
English: Ambroxol formulations for injection are also used in premature and newborn babies to treat respiratory distress syndrome, a condition in which the baby's lungs are too immature for the baby to breathe properly.
Slovenian: Pripravki ambroksola za injiciranje se uporabljajo tudi pri nedonošenčkih in novorojenčkih za zdravljenje sindroma respiratorne stiske, tj. stanja, pri katerem dojenček zaradi nezrelih pljuč ne more pravilno dihati.
English: On 18 November 2015, the CMDh1 endorsed by majority vote recommendations to update the product information for ambroxol- and bromhexine-containing medicines with information about the small risk of severe allergic reactions and severe cutaneous adverse reactions (SCARs).
Slovenian: Dne 18. novembra 2015 je skupina CMDh1 z večino glasov podprla priporočila, da se informacije o zdravilu za zdravila, ki vsebujejo ambroksol in bromheksin, posodobijo z informacijami o manjšem tveganju za resne alergijske reakcije in hude kožne neželene učinke (SCAR).
English: In making the recommendations, the PRAC evaluated available data on ambroxol and bromhexine, including reports of severe allergic reactions or SCARs.
Slovenian: Pri oblikovanju priporočil je odbor PRAC ovrednotil razpoložljive podatke o ambroksolu in bromheksinu, vključno s poročili o resnih alergijskih reakcijah in SCAR.
English: Ambroxol- and bromhexine-containing medicines are marketed as single products or as fixed combination products with various other active ingredients.
Slovenian: Zdravila, ki vsebujejo ambroksol in bromheksin, se tržijo kot samostojna zdravila ali kot zdravila v fiksni kombinaciji z različnimi drugimi zdravilnimi učinkovinami.
English: EU Member States, and is responsible for ensuring harmonised safety standards for medicines authorised via national procedures across the EU.
Slovenian: Skupina CMDh je regulativni organ, ki zastopa države članice EU in je odgovorna za zagotavljanje usklajenih varnostnih standardov za zdravila, odobrena po nacionalnih postopkih, po vsej EU.
English: • As ambroxol is a metabolite of bromhexine, the risk of anaphylactic and severe cutaneous reactions is considered to apply also to bromhexine.
Slovenian: • Ker je ambroksol presnovek bromheksina, tveganje za anafilaktične in hude kožne reakcije velja tudi za bromheksin.
English: • The risk of anaphylactic reactions and SCARs with ambroxol or bromhexine is low.
Slovenian: • Tveganje za anafilaktične reakcije in SCAR pri ambroksolu ali bromheksinu je majhno.
English: Ambroxol and bromhexine are mainly used by mouth as expectorants to help make the mucus thinner and therefore easier to be cleared away in patients with short- or long-term diseases of the lungs or airways.
Slovenian: Ambroksol in bromheksin se v glavnem uporabljata peroralno kot ekspektoransa, ki pri bolnikih s kratkotrajnimi ali dolgotrajnimi boleznimi pljuč ali dihal pripomoreta k redčenju in čiščenju sluzi.
English: • Anaphylactic reactions and severe cutaneous adverse reactions (SCARs), including erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis and acute generalised exanthematous pustulosis, have been reported in patients receiving ambroxol.
Slovenian: • Pri bolnikih, ki prejemajo ambroksol, so poročali o anafilaktičnih reakcijah in hudih kožnih neželenih učinkih (SCAR), vključno z multiformnim eritemom, Stevens-Johnsonovim sindromom/toksično epidermalno nekrolizo in akutno generalizirano eksantematozno pustulozo.
English: For ambroxol, lozenge formulations are also available to relieve sore throat.
Slovenian: Ambroksol je na voljo tudi v obliki pastil za lajšanje bolečega grla.
English: • There is a small risk of allergy and skin reactions with ambroxol and bromhexine used as expectorants to clear mucus in the airways.
Slovenian: • Pri ambroksolu in bromheksinu, ki se uporabljata kot ekspektoransa za čiščenje sluzi v dihalih, obstaja majhno tveganje za alergijo in kožne reakcije.
English: Hungary AstraZeneca Kft. Bocskai út 134-146.
Slovenian: AstraZeneca Kft. Bocskai út 134-146.
English: DK-2605 Brøndby
Slovenian: DK-2605 Brøndby Denmark
English: Cyprus Medochemie Ltd 1-10 Constantinoupoleos Street
Slovenian: Medochemie Ltd 1-10 Constantinoupoleos Street
English: GlaxoSmithKline 100, route de Versailles 78163 Marly-le-Roi Cedex France
Slovenian: Laboratoire GlaxoSmithKline 100, route de Versailles 78163 Marly-le-Roi Cedex France
English: B-1200 Woluwe-Saint
Slovenian: B-1200 Woluwe-SaintLambert
English: Ireland GlaxoSmithKline (Ireland) Limited
Slovenian: GlaxoSmithKline (Ireland) Limited
English: 1495-131 Algés, Lisbon Portugal ventilan
Slovenian: 1495-131 Algés, Lisbon
English: Glaxo Wellcome Farmacêutica, Lda.
Slovenian: Portugalska Glaxo Wellcome Farmacêutica, Lda.
English: Belgium SCS Boehringer Ingelheim SA Avenue Ariane 16
Slovenian: SCS Boehringer Ingelheim SA Avenue Ariane 16
English: Middlesex UB11 1BT United Kingdom
Slovenian: Middlesex UB11 1BT
English: Luxembourg Eumedica S.A. Av. Winston Churchill 67 B-1180 Bruxelles Belgium ritodrine
Slovenian: Luksemburg Eumedica S.A. Av. Winston Churchill 67 B-1180 Bruxelles Belgium ritodrine
English: Torre 3 - 12, 1099-036 Portugal isoxsuprine
Slovenian: Torre 3 - 12, 1099-036 Portugal isoxsuprine Dilum Retard 30mg tableta s podaljšanim sproščanjem
English: VENTOLIN®, soluţie injectabilă, 0,5 mg/ml
Slovenian: VENTOLIN®, soluţie injectabilă, 0,5 mg/ml parenteralna uporaba
English: Partusisten, concentraat voor oplossing voor intraveneuze infusie 50 microgram/ml
Slovenian: Partusisten, concentraat voor oplossing voor intraveneuze infusie 50 microgram/ml koncentrat za raztopino za infundiranje
English: Pharmaceutical forms
Slovenian: Farmacevtsk a oblika
English: Ventolin 1mg/ml Concentrate for Solution for Intravenous Infusion
Slovenian: Ventolin 1mg/ml Concentrate for Solution for Intravenous Infusion koncentrat za raztopino za intravensko infundiranje
English: Glaxo Wellcome House Berkeley Avenue
Slovenian: GLAXO WELLCOME UK Limited Glaxo Wellcome House Berkeley Avenue Greenford
English: Actavis UK Limited Whiddon Valley Barnstaple
Slovenian: Velika Britanija Actavis UK Limited Whiddon Valley
English: PRE-PAR 50MG/5ML 50mg/5ml
Slovenian: PRE-PAR 50MG/5ML
English: 3505 Lemesos Cyprus terbutaline
Slovenian: 3505 Lemesos Cyprus terbutaline ATALINE tablets 2.5 mg
English: Ireland AstraZeneca UK Limited 600 Capability Green Luton, LU1 3LU
Slovenian: Velika Britanija AstraZeneca UK Limited 600 Capability Green
English: VASOSUPRINA RETARD
Slovenian: Italy isoxsuprine VASOSUPRINA RETARD
English: Teva UK Limited Bampton Road Hampden Park Eastbourne
Slovenian: Velika Britanija Teva UK Limited Bampton Road
English: Infusionsbereitun g
Slovenian: Infusionsbereitun g koncentrat za raztopino za infundiranje
English: 1817 MS Alkmaar The Netherlands fenoterol
Slovenian: 1817 MS Alkmaar
English: SALBUMOL 1 mg, suppository
Slovenian: SALBUMOL 1 mg, suppository svečka rektalna uporaba
English: Belgium EUMEDICA N.V. Av. Winston Churchill 67 B-1180 Bruxelles Belgium ritodrine
Slovenian: Av. Winston Churchill 67 B-1180 Bruxelles Belgium ritodrine
English: Intravenous use; Intramuscular use
Slovenian: intravenska uporaba; intramuskularna uporaba
English: Boehringer Ingelheim Pharma GmbH & Co. KG Binger Str. 173
Slovenian: Boehringer Ingelheim Pharma GmbH & Co.
English: Concentrate for infusion
Slovenian: koncentrat za raztopino za infundiranje
English: Sweden AstraZeneca AB SE - 151 85 Södertälje Sweden terbutaline
Slovenian: AstraZeneca AB SE - 151 85 Södertälje Sweden terbutaline Bricanyl® 0,3mg/ml peroralna raztopina
English: France AstraZeneca 1, place Renault 92844 Rueil Malmaison Cedex
Slovenian: 1, place Renault 92844 Rueil Malmaison Cedex France terbutaline BRICANYL 0.5 mg/1 ml
English: Bricanyl Tablets 5mg
Slovenian: United Kingdom terbutaline Bricanyl Tablets 5mg
English: SALBUTAMOL MYLAN 5 mg/5 ml, solution for infusion
Slovenian: SALBUTAMOL MYLAN 5 mg/5 ml, solution for infusion raztopina za infundiranje
English: SALBUMOL FORT 5 mg / 5 ml solution for infusion
Slovenian: SALBUMOL FORT 5 mg / 5 ml solution for infusion raztopina za infundiranje
English: VENTOLIN I.M.-S.C. 0.5mg
Slovenian: VENTOLIN I.M.S.C.
English: Italy isoxsuprine
Slovenian: Italy isoxsuprine VASOSUPRINA ILFI
English: Bricanyl 0,5 mg/ml oldatos injekció
Slovenian: Hungary terbutaline Bricanyl 0,5 mg/ml oldatos injekció raztopina za injiciranje ali infundiranje
English: VENTOLIN 2 MG 2mg
Slovenian: VENTOLIN 2 MG 2mg peroralna raztopinasteklenica
English: Luxembourg GlaxoSmithKline Pharmaceuticals S.A./N.V.
Slovenian: Luksemburg GlaxoSmithKline Pharmaceuticals S.A./N.V.
English: Romania GLAXO WELLCOME UK Limited
Slovenian: Velika Britanija Glaxo Wellcome UK Limited Stockley Park West
English: Ventolin 500 micrograms/ml Solution for Injection
Slovenian: Ventolin 500 micrograms/ml Solution for Injection subkutana, intramuskularna, intravenska uporaba
English: Bricanyl Syrup 0.3mg/ml
Slovenian: United Kingdom terbutaline Bricanyl Syrup 0,3mg/ml peroralna raztopina
English: Solution for injection Intravenous use, Subcutaneous use
Slovenian: Solution for injection intravenska uporaba, subkutana uporaba
English: Boehringer Ingelheim B.V. Comeniusstraat 6
Slovenian: Nizozemska Boehringer Ingelheim B.V.
English: Ventoline
Slovenian: AstraZeneca
English: Intramuscular use, Subcutaneous use
Slovenian: intramuskularna uporaba, subkutana uporaba
English: Bricanyl
Slovenian: Uxbridge
English: VENTOLIN 4MG 4mg
Slovenian: VENTOLIN 4MG 4mg peroralna raztopina
English: Austria AstraZeneca Österreich GmbH
Slovenian: AstraZeneca Österreich GmbH Schwarzenbergplatz 7 A-1037 Vienna
English: SALBUMOL 0,5 mg/1 ml, solution for injection
Slovenian: SALBUMOL 0,5 mg/1 ml, solution for injection intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: AstraZeneca UK Limited 600 Capability Green Luton, LU1 3LU United Kingdom terbutaline
Slovenian: AstraZeneca UK Limited 600 Capability Green Luton, LU1 3LU United Kingdom terbutaline Bricanyl 500 micrograms/ml solution for injection or infusion raztopina za injiciranje ali infundiranje subkutana, intramuskularna, intravenska uporaba
English: Denmark GlaxoSmithKline Pharma A/S
Slovenian: GlaxoSmithKline Pharma A/S Nykær 68
English: Modified-release tablet
Slovenian: tableta s prirejenim sproščanjem
English: Pre-Par solution injectable
Slovenian: Pre-Par solution injectable raztopina za injiciranje ali infundiranje
English: ATALINE syrup 1.5 mg/5ml
Slovenian: 3505 Lemesos Cyprus terbutaline ATALINE syrup 1.5 mg/5ml sirup
English: Solution for injection Concentrate for solution for injection
Slovenian: Partusisten intrapartal koncentrat za raztopino za injiciranje
English: Partusisten intrapartal
Slovenian: PRE-PAR AMPOLLAS
English: Ventolin Solution for Intravenous Infusion
Slovenian: Ventolin Solution for Intravenous Infusion intravenska uporaba, subkutana uporaba
English: Takeda Austria GmbH St.-Peter-Straße 25 A -4020 Linz Austria hexoprenaline Gynipral 10 μg / 2 ml - Ampullen
Slovenian: Takeda Austria GmbH St.-Peter-Straße 25 A -4020 Linz Austria hexoprenaline Gynipral 10 μg / 2 ml - Ampullen raztopina za injiciranje ali infundiranje
English: Lambert
Slovenian: Eastbourne
English: NYCOMED Austria GmbH St.-Peter-Straße 25 A -4020 Linz Austria hexoprenaline GYNIPRAL 10 μg/2 ml
Slovenian: NYCOMED Austria GmbH St.-Peter-Straße 25 A -4020 Linz Austria hexoprenaline GYNIPRAL 10 μg/2 ml parenteralna uporaba
English: Intravenous use, Intramuscular use, Subcutaneous use
Slovenian: Ventoline intramuskularna uporaba, subkutana uporaba
English: Stonemasons Way
Slovenian: Comeniusstraat 6
English: Schwarzenbergplatz 7
Slovenian: Hampden Park
English: Austria terbutaline
Slovenian: Portugal ventilan
English: Syrup
Slovenian: Ciper
English: Norway AstraZeneca AS Innspurten 15
Slovenian: AstraZeneca AS Innspurten 15 0663 Oslo Norway terbutaline Bricanyl peroralna raztopina
English: Always carry some sugar (at least 20 grams) with you.
Slovenian: Vedno imejte s seboj nekaj sladkorja (vsaj 20 gramov).
English: Be careful not only when you start another medicine, but also when you stop it.
Slovenian: Pazite ne samo na to, kdaj začnete jemati drugo zdravilo, ampak tudi na to, kdaj ga prenehate jemati.
English: Mean GIR (% of Maximum)
Slovenian: povprečna GIR (% maksimuma)
English: Your doctor or nurse will have discussed this with you.
Slovenian: Vaš zdravnik ali medicinska sestra sta se o tem najbrž že pogovorila z vami.
English: Chamber and mouthpiece - once a week
Slovenian: Čiščenje Komora in ustnik - enkrat na teden
English: Do not force, it should easily drop into place.
Slovenian: Ne uporabljajte sile, nastavek bi moral zlahka zdrsniti na svoje mesto.
English: However, a recommended starting daily dose is based on the following formula:
Slovenian: Vendar priporočeni začetni dnevni odmerek temelji na naslednji formuli:
English: Try always to keep familiar with your warning symptoms.
Slovenian: Vedno poskušajte natančno prepoznati svoje opozorilne simptome.
English: Type 1 Diabetes
Slovenian: Diabetes tipa 1
English: These symptoms often develop before the symptoms
Slovenian: Ti simptomi se pogosto razvijejo pred simptomi nizke
English: These effects are usually transitory.
Slovenian: Ti učinki so navadno prehodni.
English: Tell your doctor about all medicines that you are taking, including those you have bought without a prescription (such as from a Pharmacy or other shop).
Slovenian: Povejte svojemu zdravniku za vsa zdravila, ki jih jemljete, tudi za tista, ki ste jih kupili brez recepta (na primer v lekarni ali kakšni drugi trgovini).
English: The manufacturer is Heinrich Mack Nachf.
Slovenian: Izdelovalec je Heinrich Mack Nachf.
English: These injections may be justified even if it is not
Slovenian: Te injekcije utegnejo biti upravičene, tudi če niste prepričani, ali imate
English: Breathe out normally.
Slovenian: Normalno izdihnite.
English: What to do in case of hypoglycaemia
Slovenian: Kaj storiti v primeru hipoglikemije
English: Do not take more insulin.
Slovenian: Ne vzemite več insulina.
English: Check your blood sugar frequently.
Slovenian: Pogosto preverite svoj krvni sladkor.
English: Always follow your doctor's instructions about when and how to take EXUBERA.
Slovenian: Vedno se ravnajte po navodilih svojega zdravnika o tem, kdaj in kako vzeti zdravilo EXUBERA.
English: Do not block the opening of the mouthpiece with your tongue or teeth.
Slovenian: Ne zamašite odprtine ustnika z jezikom ali zobmi.